U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT06869291) titled 'Observation of the Effect and Mechanism of Multi Tunnel Minimally Invasive Treatment for Xanthelasma Palpebrarum' on Feb. 26.
Brief Summary: Dear research participants:
Participants will be invited to participate in a research project led by the Dermatology Prevention and Treatment Institute of Fuzhou First General Hospital (Huang Zhiyong) (15260471946). The research project is titled "New Directions in the Treatment of Xanthelasma Palpebrarum: Research on Hematoma Related Treatment Methods and Mechanisms".
Participants' participation in this study is voluntary, and this informed consent form provides participants with some infor...